Whole-body MR with diffusion imaging matches PET/CT for lung cancer staging
A little diffusion imaging goes a long way toward boosting the accuracy of whole-body MRI and matching the performance of whole-body FDG-PET/CT for M-staging of non-small cell lung cancer.
A little diffusion imaging goes a long way toward boosting the accuracy of whole-body MRI and matching the performance of whole-body FDG-PET/CT for M-staging of non-small cell lung cancer.
Dr. Yoshiharu Ohno, an assistant professor of radiology at Kobe University Graduate School of Medicine in Japan, drew this conclusion from a prospective trial involving 203 consecutive patients. The subjects underwent whole-body anatomic MR, diffusion-weighted imaging, and whole-body FDG-PET/CT procedures. Two chest radiologists read the MR scans, and two experienced nuclear medicine physicians interpreted the PET/CT studies.
The probabilities for the presence of metastases on the three sets of images were calculated on a five-point scale on a per-patient basis. Final diagnosis was determined by consensus of the two readers. Results were confirmed with a one-year clinical follow-up.
The Kobe group found whole-body MRI with DWI is significantly more sensitive than anatomic MRI alone and slightly more sensitive than PET/CT for whole-body M-staging including the brain. The combined anatomic and functional measures were 70% sensitive for metastases compared with 60% for MRI alone. Both approaches were 92% specific for isolating metastatic disease. The sensitivity and specificity of PET/CT were 62.5% and 94.5%, respectively.
When looking at the brain alone, combined anatomic and diffusion-weighted MR imaging more accurately identified the presence and number of metastatic lesions than did FDG-PET/CT, Ohno said.
FDG-PET/CT was slightly more sensitive than MRI-DWI, however, for staging metastatic lung cancer elsewhere in the body. Its sensitivity rate was 70.6% compared with 67.6% for the integrated MRI-DWI technique. At 94.5%, the specificity rate of FDG-PET/CT was again only slightly better than the 92% rate of whole-body MRI combined with diffusion-weighted imaging.
"You need anatomic imaging from whole-body MRI and diffusion-weighted imaging," Ohno said in an interview.
His group's results were presented as a conventional scientific poster at the 2008 International Society for Magnetic Resonance Imaging in Medicine meeting in Toronto.
"If you combine the two methods, the diagnostic capability is almost equal to whole-body PET/CT for M-staging lung cancer. If you use DWI, detecting suspicious regions is easier and faster," he said.
For more information from the Diagnostic Imaging archives:
Whole-body PET/CT screening Li-Fraumeni patients for range of cancers
Whole-body cancer staging requires frequent follow-up in some patients
Whole-body MRI and PET/CT can miss many metastases
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 4th 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 4th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 4th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 4th 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
